Sunday 8 November 2026 Export IDXG’s income statement to Excel — free account

Interpace Biosciences, Inc.

IDXG

Interpace Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.7 million, down 17.5% from fiscal 2024.

Revenue: −1.09%
EPS: +104.1%
Free cash flow: −92.1%

Quarter to June 2026, against a year earlier

Operating cash flow growth 5 yrs

7.00 0.00 0.00%

Follow IDXG

Alert me

Market cap: —
P/E: 0.3×
Fwd P/E: —
Dividend yield: —
F-score: 5/9
Altman Z: −6.72
Beneish M: 2.07
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	6	5	5	6	+8 more TTM periods Free account
ROE Full definition →	221.93%	210.21%	243.97%	(11.50%)
ROA Full definition →	104.29%	98.74%	101.07%	25.58%
ROIC Full definition →	12.67%	10.33%	12.85%	0.00%
Return on Tangible Assets Full definition →	320.07%	323.25%	395.10%	70.57%
Average Days of Receivables Full definition →	63.73	59.67	53.24	51.95
Free Cash Flow per Share Full definition →	0.74	0.98	5.68	4.42
Free Cash Flow Full definition →	4.10	4.45	5.03	3.91
Capital Expenditures Full definition →	(0.35)	(0.42)	(0.81)	(0.96)
Other line items
Cash ROIC Full definition →	15.83%	17.31%	20.21%	347.73%
Accounts Receivable Turnover Full definition →	5.34	4.93	5.46	6.32
Accounts Payable Turnover Full definition →	9.34	10.70	11.05	10.23
Inventory Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	43.32	21.64	24.58	32.34
Days of Inventory on Hand Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	5.22	6.67	5.62	0.00
Research and Development Expense of Revenue Full definition →	1.64%	1.71%	1.66%	1.66%
Selling, General and Administrative Expense of Revenue Full definition →	50.58%	51.51%	50.10%	49.46%
Share Based Compensation of Revenue Full definition →	0.05%	0.07%	0.09%	0.25%
Operating CF/Net income Full definition →	0.18	0.21	0.24	1.46
Depreciation/Fixed assets Full definition →	0.57	0.69	0.62	0.55
Capex/Depreciation Full definition →	(0.38)	(0.47)	(0.92)	(1.13)
Revenue per Share Full definition →	6.52	7.95	43.77	47.36
Operating CF per Share Full definition →	0.80	1.07	6.59	5.51
Capex per Share Full definition →	(0.06)	(0.09)	(0.91)	(1.09)
Capex to Sales Full definition →	0.01	0.01	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly